KR0149029B1 - 지사제 조성물 - Google Patents

지사제 조성물

Info

Publication number
KR0149029B1
KR0149029B1 KR1019910018463A KR910018463A KR0149029B1 KR 0149029 B1 KR0149029 B1 KR 0149029B1 KR 1019910018463 A KR1019910018463 A KR 1019910018463A KR 910018463 A KR910018463 A KR 910018463A KR 0149029 B1 KR0149029 B1 KR 0149029B1
Authority
KR
South Korea
Prior art keywords
loperamide hydrochloride
syrup
composition
hydrochloride
loperamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019910018463A
Other languages
English (en)
Korean (ko)
Other versions
KR920007627A (ko
Inventor
도시야끼 구라즈미
히로유끼 미즈노
가쯔미 이마모리
아끼라 이와사
Original Assignee
다이또 나오가따
에스에스 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이또 나오가따, 에스에스 세이야꾸 가부시끼 가이샤 filed Critical 다이또 나오가따
Publication of KR920007627A publication Critical patent/KR920007627A/ko
Application granted granted Critical
Publication of KR0149029B1 publication Critical patent/KR0149029B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1019910018463A 1990-10-24 1991-10-19 지사제 조성물 Expired - Fee Related KR0149029B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2286458A JP2711759B2 (ja) 1990-10-24 1990-10-24 止瀉剤組成物
JP90-286458 1990-10-24

Publications (2)

Publication Number Publication Date
KR920007627A KR920007627A (ko) 1992-05-27
KR0149029B1 true KR0149029B1 (ko) 1998-10-15

Family

ID=17704653

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910018463A Expired - Fee Related KR0149029B1 (ko) 1990-10-24 1991-10-19 지사제 조성물

Country Status (8)

Country Link
US (2) US5182112A (https=)
EP (1) EP0482580B1 (https=)
JP (1) JP2711759B2 (https=)
KR (1) KR0149029B1 (https=)
CA (1) CA2054017A1 (https=)
DE (1) DE69128760T2 (https=)
ES (1) ES2113358T3 (https=)
TW (1) TW201690B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
US5849762A (en) * 1997-07-14 1998-12-15 Adolor Corporation Peripherally acting anti-pruritic opiates
US6353004B1 (en) 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
JP4731777B2 (ja) * 1999-10-12 2011-07-27 マルホ株式会社 経口医薬組成物
US6365152B1 (en) 2001-03-15 2002-04-02 Bovine Health Products, Inc. Scours treatment and method of making same
FR2845600B1 (fr) * 2002-10-09 2005-07-08 Innovations Pharma Ag Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte
KR20050001548A (ko) * 2003-06-25 2005-01-07 동화약품공업주식회사 항설사용 약제학적 조성물
EP2131811B1 (fr) * 2007-03-14 2020-03-04 Vetinnov Produit appétent
FR2913601B1 (fr) * 2007-03-14 2009-10-30 Vetinnov Sarl Support appetent a formule amelioree
ITRM20120341A1 (it) 2012-07-17 2014-01-18 Er La Salute Della Donna E Del Bambino Soluzione glucosalina di mantenimento per la somministrazione parenterale ad uso pediatrico
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
CN104546736A (zh) * 2014-12-25 2015-04-29 北京科源创欣科技有限公司 小儿盐酸洛哌丁胺颗粒及其制备工艺
JP7459458B2 (ja) * 2018-06-28 2024-04-02 ライオン株式会社 内服組成物及びその製造方法
CN111450050A (zh) * 2019-01-22 2020-07-28 北京万全德众医药生物技术有限公司 盐酸洛哌丁胺口服溶液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571011B2 (en) * 1983-10-07 1988-03-31 State Of Victoria, The Treatment of neonatal calf diarrhoea
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4824853A (en) * 1985-10-11 1989-04-25 Janssen Pharmaceutica N.V. α,α-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, N-oxides and method of treating diarrhea
JPS62138147A (ja) * 1985-12-12 1987-06-20 Snow Brand Milk Prod Co Ltd ガラクトオリゴ糖類配合飼料
JP2831004B2 (ja) * 1988-09-29 1998-12-02 大日本製薬株式会社 粉粒状医薬製剤
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
US5219573A (en) * 1989-10-17 1993-06-15 Hershey Foods Corporation L-sugar laxatives
NZ235876A (en) * 1989-11-01 1992-06-25 Mcneil Ppc Inc Pharmaceutical compositions containing effective amount of antidiarrheal composition and antiflatulent effective amount of simethicone
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物

Also Published As

Publication number Publication date
JP2711759B2 (ja) 1998-02-10
EP0482580B1 (en) 1998-01-21
US5182112A (en) 1993-01-26
EP0482580A1 (en) 1992-04-29
DE69128760D1 (de) 1998-02-26
US5348744A (en) 1994-09-20
JPH04159223A (ja) 1992-06-02
KR920007627A (ko) 1992-05-27
CA2054017A1 (en) 1992-04-25
TW201690B (https=) 1993-03-11
ES2113358T3 (es) 1998-05-01
DE69128760T2 (de) 1998-04-30

Similar Documents

Publication Publication Date Title
KR0149029B1 (ko) 지사제 조성물
US5229137A (en) Methods and pharmaceutical compositions for treating episodic heartburn
KR960016582B1 (ko) 위장장해의 치료 및 예방용 약제학적 조성물
US20020071872A1 (en) Laxative composition
JPH08512322A (ja) Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物
RU2126249C1 (ru) Фармацевтическая композиция для перорального введения для лечения патологического состояния верхних отделов желудочно-кишечного тракта
CZ225893A3 (en) Chewing antacid preparation
CN101926818A (zh) 一种含有茶多酚和海藻酸的药物组合及其用途
JPH08512321A (ja) Ｈ▲下２▼拮抗剤−アルギネート−制酸剤の組合せ物
US3094464A (en) Aspirin-antacid polysiloxane tablet
US4465667A (en) Process for the preparation of gastric acid neutralizing agents, gastric acid neutralizing agents, and a method for treating hyperacidity and disorders related thereto
WO1997000075A1 (fr) Medicament contre le prurit cutane accompagnant l'insuffisance renale
WO1995001780A1 (en) H2 antagonist-alginate combinations
US6169083B1 (en) Preventives/remedies for stomatitis
US4981852A (en) Chemical compounds triamterene and hydrochlorothiazide
EP0777470A1 (en) Use of paracellular absorption enhancers such as glucose for enhancing the absorption of histamine h2-antagonists
CN105878263B (zh) 含有苹果酸氯波必利的药物组合物及其应用
US3055805A (en) Process of treating acidosis with t.h.a.m.
JPH0132804B2 (https=)
KR20050001548A (ko) 항설사용 약제학적 조성물
RU2751351C2 (ru) Пероральный препарат ибупрофена
KR960011773B1 (ko) 궤양의 예방 및 치료용 의약 조성물
ES2316368T3 (es) Lactoalbumina para el tratamiento curativo de ulceras peptidicas.
US20090175933A1 (en) Preparation for the treatment of diarrhoea
JP2002537345A (ja) 腸機能調整用調合薬

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20010603

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20010603

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000